DDX5 helicase resolves G-quadruplex and is involved in MYC gene transcriptional activation
Significance
G-quadruplexes (G4) are 4-stranded nucleic acid secondary structures. MYC is a critical oncogene with a G4 in its promoter (MycG4), which acts as a transcription silencer. MycG4 is very stable and the pathological activation of MYC in cancers requires its active unfolding. We reveal herein that DDX5, a founding member of the DEAD-box RNA helicase family, can unfold DNA G4s. The unfolding mechanism of DDX5 is distinct from previously characterized G4 helicases. Importantly, DDX5 activates MYC gene transcription by proficiently unfolding the promoter MycG4. DDX5 is overexpressed in cancers and the DDX5–MycG4 interaction can be inhibited by small molecules to downregulate MYC . Therefore, our results suggest a new molecular target to suppress MYC for cancer intervention.
Top-30
Journals
1
2
3
4
5
|
|
Molecules
5 publications, 5.05%
|
|
Journal of the American Chemical Society
5 publications, 5.05%
|
|
Nucleic Acids Research
5 publications, 5.05%
|
|
International Journal of Molecular Sciences
4 publications, 4.04%
|
|
Biochemical and Biophysical Research Communications
4 publications, 4.04%
|
|
Genes
3 publications, 3.03%
|
|
Journal of Biological Chemistry
3 publications, 3.03%
|
|
Communications Biology
2 publications, 2.02%
|
|
Computational and Structural Biotechnology Journal
2 publications, 2.02%
|
|
Methods
2 publications, 2.02%
|
|
iScience
2 publications, 2.02%
|
|
Journal of Medicinal Chemistry
2 publications, 2.02%
|
|
Life Science Alliance
2 publications, 2.02%
|
|
Bioengineered
2 publications, 2.02%
|
|
Journal of Biochemistry
2 publications, 2.02%
|
|
Biological Chemistry
2 publications, 2.02%
|
|
Biochemistry and Cell Biology
1 publication, 1.01%
|
|
Cancers
1 publication, 1.01%
|
|
Frontiers in Molecular Biosciences
1 publication, 1.01%
|
|
Frontiers in Oncology
1 publication, 1.01%
|
|
Signal Transduction and Targeted Therapy
1 publication, 1.01%
|
|
Nature Communications
1 publication, 1.01%
|
|
Cell Death Discovery
1 publication, 1.01%
|
|
Nature Reviews Genetics
1 publication, 1.01%
|
|
Journal of Controlled Release
1 publication, 1.01%
|
|
Analytical and Bioanalytical Chemistry
1 publication, 1.01%
|
|
Cell Reports
1 publication, 1.01%
|
|
International Journal of Biological Macromolecules
1 publication, 1.01%
|
|
PLoS Genetics
1 publication, 1.01%
|
|
1
2
3
4
5
|
Publishers
5
10
15
20
25
|
|
Elsevier
23 publications, 23.23%
|
|
MDPI
14 publications, 14.14%
|
|
American Chemical Society (ACS)
10 publications, 10.1%
|
|
Springer Nature
9 publications, 9.09%
|
|
Oxford University Press
9 publications, 9.09%
|
|
Cold Spring Harbor Laboratory
7 publications, 7.07%
|
|
Frontiers Media S.A.
4 publications, 4.04%
|
|
Taylor & Francis
3 publications, 3.03%
|
|
American Society for Biochemistry and Molecular Biology
2 publications, 2.02%
|
|
Rockefeller University Press
2 publications, 2.02%
|
|
Walter de Gruyter
2 publications, 2.02%
|
|
Wiley
2 publications, 2.02%
|
|
Canadian Science Publishing
1 publication, 1.01%
|
|
Public Library of Science (PLoS)
1 publication, 1.01%
|
|
Pleiades Publishing
1 publication, 1.01%
|
|
BMJ
1 publication, 1.01%
|
|
American Association for Cancer Research (AACR)
1 publication, 1.01%
|
|
IOP Publishing
1 publication, 1.01%
|
|
Royal Society of Chemistry (RSC)
1 publication, 1.01%
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 1.01%
|
|
5
10
15
20
25
|
- We do not take into account publications without a DOI.
- Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
- Statistics recalculated weekly.